(Q34991479)

5 August 2017

1 reference

title

Anastrozole: in early breast cancer (English)

1 reference

5 August 2017

1 reference

Keri Wellington

1

1 reference

5 August 2017

Diana M Faulds

series ordinal

2

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

62

1 reference

5 August 2017

issue

17

1 reference

5 August 2017

page(s)

2483-90; discussion 2491-2

1 reference

Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women

5 August 2017

cites work

1 reference

12 December 2020

Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer

1 reference

12 December 2020

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

12 December 2020

Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial

1 reference

12 December 2020

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

1 reference

12 December 2020

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

1 reference

12 December 2020

Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancer

1 reference

12 December 2020

Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.

1 reference

12 December 2020

Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers

1 reference

12 December 2020

Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer

1 reference

12 December 2020

Arimidex: a potent and selective fourth-generation aromatase inhibitor

1 reference

12 December 2020

The place of chemotherapy in the treatment of early breast cancer

1 reference

12 December 2020

10.2165/00003495-200262170-00010

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1002401004

0 references

1 reference